Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120212) titled 'Predicting Immunotherapy Response in Advanced NSCLC Using ?CT Radiomics Combined with Lung Immune Prognostic Index (LIPI):A Predictive Model Study' on March 11.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Shaoxing People's Hospital

Condition: Non-Small Cell Lung Cancer NSCLC

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-03-15

Target Sample Size: Observation group:100;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=313251

Published by HT Digital Content Services with permission from Hea...